Thu May 31, 2012

If you want to increase your car's gas mileage or build a more powerful handheld electronic device, don't bend steel or slice silicon chips. Manipulate nanomaterials and molecules instead.

Wed May 30, 2012

"Using ultraviolet light, chemists have reversibly immobilized molecules on surfaces (J. Am. Chem. Soc., DOI: 10.1021/ja302970x). The technique could be used to develop repairable microarrays or to study how biochemical events on surfaces progress with time. 

Light-mediated reactions are nothing new when it comes to decorating surfaces for bioanalytical chemistry. But most techniques are irreversible or make it difficult to reuse a surface.

Fri May 25, 2012

Gregory H. Robinson, Franklin Professor and Distinguished Research Professor of Chemistry at the University of Georgia, is one of a select group of international academics awarded a 2012 Humboldt Research Award from Germany's Alexander von Humboldt Foundation.

Tue Apr 17, 2012

Geert-Jan Boons, Franklin Professor of Chemistry, was awarded the Inventor's Award in the 2012 Creative Research Awards. The award recognizes an inventor for a unique and innovative discovery that has made an impact on the community.

Tue Apr 10, 2012

The Southeastern Universities Research Association announced Henry F. Schaefer III, Graham Perdue Professor of Chemistry at the University of Georgia, as its 2012 SURA Distinguished Scientist Award.

Thu Jan 5, 2012

Assistant Professor Shanta Dhar has been granted a three-year Idea development Award from the Department of Defense Congressionally Directed Prostate Cancer Research Program (DoD-PCRP) for her grant entitled, “Combined Chemotherapy and Anti-Inflammatory Therapy for Metastatic Castration-Resistant

Tue Dec 13, 2011

If genes provide the blueprint for life and proteins are the machines that do much of the work for cells, then carbohydrates linked to proteins are among the tools that enable cells to communicate with the outside world and each other.

Wed Dec 14, 2011

Researchers from the University of Georgia and the Mayo Clinic in Arizona have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases—including those resistant to common treatments.